Company · CIK 1746473
PLIANT THERAPEUTICS, INC.
| CIK | 1746473 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | PLRX (Nasdaq) |
| First annual or quarterly report | 2020-08-11 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-294737 | 2026-03-30 | 2026-04-06 | 2 | |
| 333-270862 | 2023-03-27 | 2023-03-27 | 1 | |
| 333-257684 | 2021-07-02 | 2023-01-25 | 6 | |
| 333-238146 | 2020-05-11 | 2020-06-03 | 5 |
Filings
15| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-04-06 | EFFECTDeclared effective | 333-294737 | 9999999995-26-001103 |
| 2026-03-30 | S-3Shelf registered | 333-294737 | 0001193125-26-131933 |
| 2023-03-27 | S-3ASRShelf registered | 333-270862 | 0001193125-23-080421 |
| 2023-01-25 | 424B5Shelf takedown | 333-257684 | 0001193125-23-015268 |
| 2023-01-23 | 424B5Shelf takedown | 333-257684 | 0001193125-23-013261 |
| 2022-07-14 | 424B5Shelf takedown | 333-257684 | 0001193125-22-193653 |
| 2022-07-11 | 424B5Shelf takedown | 333-257684 | 0001193125-22-191255 |
| 2022-05-31 | EFFECTDeclared effective | 333-257684 | 9999999995-22-001633 |
| 2021-07-02 | S-3ASRShelf registered | 333-257684 | 0001193125-21-207743 |
| 2020-06-03 | 424B4Final prospectus | 333-238146 | 0001193125-20-159718 |
| 2020-06-02 | EFFECTDeclared effective | 333-238146 | 9999999995-20-001313 |
| 2020-06-02 | S-1/AAmendment | 333-238146 | 0001193125-20-157787 |
| 2020-05-26 | S-1/AAmendment | 333-238146 | 0001193125-20-150643 |
| 2020-05-11 | S-1Registration filed | 333-238146 | 0001193125-20-137876 |
| 2019-05-10 | DRSDraft made public | 377-02641 | 0000950123-19-004421 |